PeptidesEvidence: Moderate

MK-677 (Ibutamoren): The Oral Secretagogue With Real Trials and Real Trade-offs

Written by: Daniel Reyes, PhD
Medically reviewed by: Dr. Sarah Lindqvist, MD
Published: June 20, 2025
Updated: June 20, 2025
Last medical review: June 20, 2025
Reviewer scope: Metabolic health

Gold capsules on a blue surface — MK-677 ibutamoren is an orally active ghrelin agonist with year-long randomized trial data

MK-677 (ibutamoren) is an orally active ghrelin-receptor agonist — not technically a peptide — with genuine randomized human trials. A year-long study in healthy older adults showed sustained GH/IGF-1 elevation and about 1.1 kg lean-mass gain versus placebo, but also increased appetite, fluid retention, and rises in fasting glucose. It remains unapproved, and a heart-failure trial was stopped over adverse signals.

The trial worth knowing

In 65 healthy 60–81-year-olds over 12 months, daily oral MK-677 restored IGF-1 to young-adult ranges and added modest fat-free mass without strength improvements. Side effects were the GH-axis usual suspects: appetite increase, mild edema, transient insulin-sensitivity reduction.

Nutrition bowl illustrating MK-677’s most reliable effect — appetite stimulation, a feature for cachexia research and a bug for fat loss

The signals marketing omits

Fasting glucose and HbA1c drift upward in multiple studies
A congestive-heart-failure trial was halted for adverse events
Appetite stimulation is reliable — a feature for cachexia research, a bug for fat loss
Long-term unsupervised use in healthy adults is uncharted

The injectable secretagogues MK-677 gets compared against are covered in the ipamorelin guide and the CJC-1295 DAC guide. The field overview is the peptide cheat sheet; appetite and energy trade-offs start with the TDEE calculator; statuses compare in the peptide comparison table.

Status and bottom line

Never approved, still sold as a "research chemical," prohibited for tested athletes. It is the best-evidenced compound in the secretagogue aisle and still a metabolic trade-off nobody should make without labs and a clinician.

Frequently asked questions

Is MK-677 a peptide?

No — it is an orally active small-molecule ghrelin-receptor agonist, which is exactly why it survives digestion without injections. It gets grouped with peptides because it stimulates the same GH axis as injected secretagogues.

What did the year-long MK-677 trial show?

In 65 healthy adults aged 60–81, twelve months of daily MK-677 restored IGF-1 to young-adult ranges and added about 1.1 kg of fat-free mass versus placebo, without strength gains — alongside increased appetite, mild edema, and reduced insulin sensitivity.

Does MK-677 raise blood sugar?

Multiple studies show fasting glucose and HbA1c drifting upward — the most consequential trade-off for long-term unsupervised use, and the reason baseline labs and monitoring would matter if any clinician were involved.

Is MK-677 legal for athletes?

It is prohibited for tested athletes and remains unapproved for any medical use — sold as a "research chemical." A congestive-heart-failure trial was halted over adverse events, a data point marketing rarely mentions.

Questions to ask a licensed clinician

How would we monitor glucose if any secretagogue were ever appropriate?
Does my cardiac history matter here?

References

Nass R, Pezzoli SS, Oliveri MC, et al. (2008). Effects of an oral ghrelin mimetic (MK-677) on body composition and clinical outcomes in healthy older adults. Annals of Internal Medicine. SourceRCT
World Anti-Doping Agency (2024). The Prohibited List — S2 peptide hormones, growth factors and related substances. WADA. SourceAgency list

Related tools

Related guides

Something incorrect in this guide? Report a correction. Material corrections are noted on the page with the date and nature of the change.